EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Metabolomic Profiling of Fecal Samples Reveals Distinct Signatures Associated with Disease Phenotypes and Locations in Crohn’s Disease

Tingyi Tan, Matthew Vincent, Umang Jain, Parakkal Deepak, SPARC I. B. D. Investigators

Digestive Diseases and Sciences · 2026

DOI: 10.1007/s10620-026-09779-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Digestive Diseases and Sciences, 2026. Verfasst von Tingyi Tan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, John T. Milliken Department of Medicine, Washington University School of Medicine, 660 Euclid Avenue, St. Louis, MO, US…. Hauptthemen laut MEDLINE: Crohn Disease, Feces, Metabolomics. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIDDK NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Crohn's disease is a heterogeneous, transmural inflammatory condition that can involve any segment of the gastrointestinal tract. Distinct locations (ileal, colonic, ileocolonic) and phenotypes (inflammatory, stricturing, penetrating) display different clinical behaviors and complication risks in CD. Whether these location- and phenotype-specific patterns correspond to unique metabolomic profiles remains incompletely defined. METHODS: To identify metabolites associated with disease activity, location, and phenotype, ultrahigh performance liquid chromatography-tandem mass spectroscopy-based metabolomic analysis was performed on stool samples from patients with CD. Active CD was defined as patients with fecal calprotectin above 100 μg/g. Metabolite differences among groups were assessed using permutational multivariate analysis of variance. Candidate metabolites were identified and validated using multivariable linear models adjusting for demographic covariates, with false discovery rate correction. RESULTS: A total of 302 stool samples from patients with CD were analyzed. Complicated CD phenotypes (B2 and B3) showed increased acylcarnitines and secondary bile acids compared with inflammatory (B1) phenotype. Location-specific analysis indicated increased cholate, and N-acyl ethanolamides in ileal and ileocolonic compared to colonic CD. When stratified by inflammation using fecal calprotectin, patients with active disease displayed upregulation of methylysine, ceramide, sphingomyelin, and polyamines. CONCLUSION: This study reveals metabolomic differences across CD phenotypes and disease activity, providing potential noninvasive biomarkers to help risk-stratify patients for complications and guide tailored management. Further validation in larger cohorts is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseFecesMetabolomicsHumansFemaleMalePhenotypeAdultLeukocyte L1 Antigen ComplexBiomarkersYoung AdultChromatography, High Pressure LiquidMetabolomeMiddle AgedIleumTandem Mass Spectrometry

Stichwörter der Autor:innen

BiomarkersCrohn’s diseaseFecal metabolomics

Substanzen

Leukocyte L1 Antigen ComplexBiomarkers

Autor:innen und Institutionen

  • Division of Gastroenterology, John T. Milliken Department of Medicine, Washington University School of Medicine, 660 Euclid Avenue, St. Louis, MO, USA.
  • Department of Pathology and Immunology, Washington University School of Medicine, 660 Euclid Avenue, St. Louis, MO, USA.
  • Division of Gastroenterology, John T. Milliken Department of Medicine, Washington University School of Medicine, 660 Euclid Avenue, St. Louis, MO, USA. Deepak.parakkal@wustl.edu.

Förderung

  • NIDDK NIH HHS
  • NIH HHS
  • National Institutes of Health
  • American College of Gastroenterology
  • Crohn's and Colitis Foundation of America

Zitieren

APA

Tan, T., Vincent, M., Jain, U., Deepak, P., & SPARC I. B. D. Investigators (2026). Metabolomic Profiling of Fecal Samples Reveals Distinct Signatures Associated with Disease Phenotypes and Locations in Crohn’s Disease. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-026-09779-9

Vancouver

Tan T, Vincent M, Jain U, Deepak P, SPARC I. B. D. Investigators. Metabolomic Profiling of Fecal Samples Reveals Distinct Signatures Associated with Disease Phenotypes and Locations in Crohn’s Disease. Digestive Diseases and Sciences. 2026. doi:10.1007/s10620-026-09779-9

BibTeX
@article{Tan2026,
  author = {Tan, Tingyi and Vincent, Matthew and Jain, Umang and Deepak, Parakkal and SPARC I. B. D. Investigators, SPARC I. B. D. Investigators},
  title = {Metabolomic Profiling of Fecal Samples Reveals Distinct Signatures Associated with Disease Phenotypes and Locations in Crohn’s Disease},
  journal = {Digestive Diseases and Sciences},
  year = {2026},
  doi = {10.1007/s10620-026-09779-9}
}
Kostenlos starten →